Blueprint Medicines is a startup based in the United States.
Blueprint Medicines is a company headquartered in the United States.
Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted small-molecule kinase inhibitors and precision therapies for genomically defined cancers and rare diseases. The company advances clinical and preclinical programs focused on oncology and genetic disease indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.